PATENT CLAIM ANALYSIS

Application Number: 15962575
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "440000"]

Abstract:
The present invention relates, in certain embodiments, to methods for preventing and/or treating neurodegenerative damage (e.g., secondary cascade of neurodegenerative damage) and improving functional outcomes (e.g., outcomes associated with cognitive, behavior and sensorimotor function) caused by traumatic brain injury using neuroprotective lipoyl compounds. The present invention also provides, in various embodiments, compositions for use in treating and/or preventing TBI in a subject in need thereof, compounds for use in the manufacture of a medicament for treating and/or preventing TBI in a subject in need thereof, and methods of preparing a pharmaceutical composition for treating and/or preventing secondary brain damage caused by TBI.

Claim (Index 2):
The method of  claim 1 , wherein the compound is a compound of Structural Formula I(a): or a pharmaceutically acceptable salt or prodrug thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 2.01724
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11709456', '12438291', '13885289', '15304958', '09246307']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7685086054869312
- 35 USC 102 Novelty (BERT): 0.4968597959352253
- Combined Prediction Score: 0.7413437245317607
- Mean Citation Score: 244.36898
- Max Citation Score: 248.37244
- Similarity Product: 192.50727350452183

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test